文献速递血液净化与透析水电解质与酸碱

终末期肾病对糖代谢的影响:匹配队列分析

Impact of end-stage renal disease on glucose metabolism-a matched cohort analysis.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

本研究对107例无糖尿病的终末期肾病(ESRD)患者(90例血透、17例腹透)进行口服葡萄糖耐量试验(OGTT)及胰岛素敏感性与分泌指数评估,并与肾功能正常的匹配对照比较。结果显示ESRD患者空腹血糖更低,匹配OGTT血糖后胰岛素敏感性显著降低,但校正甘油三酯后该差异消失;胰岛素分泌显著增高,为对胰岛素抵抗的代偿反应,而非清除受损。

要点

  • ESRD患者胰岛素敏感性降低,但校正甘油三酯后差异消失。
  • ESRD患者胰岛素分泌显著增高,为代偿性反应。
  • ESRD患者空腹血糖显著低于匹配对照。

核心结论

  • ESRD患者糖代谢与肾功能正常者显著不同,表现为胰岛素抵抗和代偿性胰岛素分泌增加。

研究设计与样本

  • 研究纳入107例无糖尿病的ESRD患者(90例血透、17例腹透),来自欧洲大学医院肾移植等待名单,进行OGTT并计算胰岛素敏感性与分泌指数。
  • 匹配对照来自TUEF研究队列,为肾功能正常、非糖尿病但2型糖尿病风险增高的健康个体,共两个匹配队列各107例。
  • 匹配条件:队列1匹配性别、年龄、BMI;队列2匹配性别、年龄、BMI、空腹血糖及OGTT 2小时血糖。

主要发现

  • ESRD患者空腹血糖显著低于对照。
  • 额外匹配OGTT血糖后,ESRD患者胰岛素敏感性显著低于对照。
  • 校正甘油三酯水平后,胰岛素敏感性差异消失。
  • ESRD患者胰岛素分泌显著高于对照。
  • OGTT期间胰岛素动力学及C肽水平表明胰岛素分泌增高是对胰岛素敏感性降低的代偿,而非胰岛素清除受损。

临床怎么用

  • 在评估ESRD患者糖代谢时,需考虑胰岛素抵抗和代偿性高胰岛素分泌的病理生理特征。

局限性

  • 对照来自2型糖尿病风险增高的健康人群,可能影响外推性。
  • 样本仅包括等待肾移植的ESRD患者,代表性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Renal function is known to affect glucose metabolism. The aim of this study was to assess glucose metabolism in end-stage renal disease (ESRD) patients and in matched controls with normal renal function and to delineate its underlying pathophysiology. METHODS: ESRD patients without diabetes mellitus on the active kidney transplant waiting list of a large European university hospital were metabolically phenotyped by an oral glucose tolerance test (OGTT) and by calculating insulin sensitivity and secretion indices. Matched controls with normal renal function were derived from the TUEF (Tuebingen Family) study cohort, which includes healthy non-diabetic individuals with an increased risk of developing type 2 diabetes. Matches were made for (i) gender, age and body mass index (BMI) (cohort 1) and for (ii) gender, age, BMI, fasting plasma glucose (FPG) and 2-h glucose in OGTT (cohort 2). RESULTS: A total of 107 patients (90 on haemodialysis and 17 on peritoneal dialysis) and two cohorts, each comprising 107 matched controls, were investigated. ESRD patients had significantly lower FPG. Additional matching for OGTT glucose concentrations revealed significantly lower insulin sensitivity in ESRD patients than in controls. This finding was abrogated after adjustment for triglyceride levels. Insulin secretion, however, was significantly higher in ESRD patients. Insulin kinetics during OGTT as well as C-peptide levels demonstrate higher insulin secretion to be a compensation for lower insulin sensitivity and not to result from impaired insulin clearance. CONCLUSION: Our study is the first to provide metabolic phenotyping in patients with ESRD and to compare them with matched controls with normal renal function. Glucose metabolism differs substantially between cohorts, with insulin resistance and a compensatory increase in insulin secretion in ESRD patients.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Guthoff M, Wagner R, Vosseler D, et al. Impact of end-stage renal disease on glucose metabolism-a matched cohort analysis. Nephrol Dial Transplant. 2017. PMID: 28407130. doi:10.1093/ndt/gfx018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。